Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study.

Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM.

Clin Infect Dis. 2008 Dec 1;47(11):1367-71. doi: 10.1086/592970.

2.

Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota.

Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM.

J Infect. 2009 Sep;59(3):188-93. doi: 10.1016/j.jinf.2009.07.004.

3.

Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota.

Tsigrelis C, Tleyjeh IM, Huskins WC, Lahr BD, Nyre LM, Virk A, Baddour LM.

Mayo Clin Proc. 2009 Oct;84(10):871-5. doi: 10.1016/S0025-6196(11)60504-1.

4.

Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.

Wagenvoort GH, Sanders EA, Vlaminckx BJ, Elberse KE, de Melker HE, van der Ende A, Knol MJ.

Vaccine. 2016 Feb 17;34(8):1077-85. doi: 10.1016/j.vaccine.2015.12.066.

PMID:
26778420
5.

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

Rudnick W, Liu Z, Shigayeva A, Low DE, Green K, Plevneshi A, Devlin R, Downey J, Katz K, Kitai I, Krajden S, Ostrowska K, Richardson D, Richardson S, Sarabia A, Silverman M, Simor AE, Tyrrell G, McGeer A; Toronto Invasive Bacterial Diseases Network..

Vaccine. 2013 Dec 2;31(49):5863-71. doi: 10.1016/j.vaccine.2013.09.049.

PMID:
24099873
6.

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network..

JAMA. 2001 Apr 4;285(13):1729-35.

PMID:
11277827
7.

Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study.

Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Sørensen HT, Schønheyder HC.

Diabetes Care. 2004 Jan;27(1):70-6.

PMID:
14693969
8.

Invasive pneumococcal disease in Australia, 2006.

Roche PW, Krause V, Cook H, Barralet J, Coleman D, Sweeny A, Fielding J, Giele C, Gilmour R, Holland R, Kampen R; Enhanced Invasive Pneumococcal Disease Surveillance Working Group., Brown M, Gilbert L, Hogg G, Murphy D; Pneumococcal Working Party of the Communicable Diseases Network Australia..

Commun Dis Intell Q Rep. 2008 Mar;32(1):18-30.

9.

Invasive pneumococcal disease in Australia, 2005.

Roche P, Krause V, Cook H, Bartlett M, Coleman D, Davis C, Fielding J, Giele C, Gilmour R, Holland R, Kampen R; Enhanced Invasive Pneumococcal Diseases Surveillance Working Group..

Commun Dis Intell Q Rep. 2007 Mar;31(1):86-100.

10.

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.

Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ.

Ann Intern Med. 2000 Feb 1;132(3):182-90.

PMID:
10651598
11.

Invasive pneumococcal disease in Australia, 2004.

Roche PW, Krause VL, Bartlett M, Coleman D, Cook H, Davis C, Fielding JE, Holland R, Giele C, Gilmour R, Kampen R, Brown M, Gilbert L, Hogg G, Murphy D; Pneumococcal Working Party of the Communicable Diseases Network Australia..

Commun Dis Intell Q Rep. 2006;30(1):80-92.

12.
13.

Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.

Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.

Clin Infect Dis. 2010 May 1;50(9):1238-46. doi: 10.1086/651680.

PMID:
20367225
14.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
15.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032.

PMID:
24176490
16.

Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan.

Liao WH, Lin SH, Lai CC, Tan CK, Liao CH, Huang YT, Wang CY, Hsueh PR.

Eur J Clin Microbiol Infect Dis. 2010 Apr;29(4):489-92. doi: 10.1007/s10096-010-0873-7.

PMID:
20108017
17.
18.

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8.

PMID:
17583392
19.

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team..

JAMA. 2005 Oct 26;294(16):2043-51.

PMID:
16249418
20.

Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.

Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW, Buck GE.

Pediatr Infect Dis J. 2005 Apr;24(4):320-3.

PMID:
15818291

Supplemental Content

Support Center